Medication Advisory

TO:	DDS Regional Directors, STS Director, CTH Coordinators, Private Providers, CO Quality Management Personnel
FROM:	David Carlow, Director, Health Services
DATE:	April 21, 2009
RE:	MEDICATION ADVISORY: FDA MedWatch - Influend Cough and Cold Products: Recall due to possibility of product being superpotent

Medication Advisory

ION Labs and FDA notified consumers and healthcare professionals of the recall of all Influend Cough and Cold products sold on or after May 30, 2008 due to the possibility that the products may be superpotent with possible complications ranging from tachycardia, palpitations, arrhythmias, and cardiovascular collapse with hypotension to headaches, dizziness, anxiety, restlessness and nervousness. Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this product.

Read the complete MedWatch 2009 Safety Summary, including a link to the firm's press release, at:
http://www.fda.gov/medwatch/safety/2009/safety09.htm#Influend

Please ensure those responsible are aware of this medication advisory. Per the direction of the DDS Director of Health Services all agencies (public and private) should forward this information to their nursing staff. Any questions regarding this medication advisory should be directed to David Carlow, DDS Director of Health Services at (860) 418-6083.